Basic Information
ID: ALA3057815
Type: Functional
Description: Antiviral activity against wild type Human immunodeficiency virus 1 infected human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 4 days by MTT assay
Organism: Human immunodeficiency virus 1
Cell type: MT4
Activity Charts
Bioactivity
Activity Types for Assay ALA3057815
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 337.25 | 2.77 | 2.77 |
| 321.33 | 2.54 | 2.54 |
| 295.29 | 2.14 | 2.14 |
| 345.30 | 2.81 | 2.81 |
| 388.76 | 3.09 | 3.09 |
| 335.31 | 2.07 | 2.07 |
| 378.77 | 2.36 | 2.36 |
| 337.32 | 2.30 | 2.30 |
| 380.78 | 2.58 | 2.58 |
| 400.61 | 4.25 | 4.25 |
| 366.71 | 3.39 | 3.39 |
| 359.23 | 3.62 | 3.62 |
| 344.75 | 4.13 | 4.13 |
| 343.21 | 5.60 | 5.60 |
| 353.76 | 4.86 | 4.86 |
| 367.24 | 5.36 | 5.36 |
| 330.73 | 2.19 | 2.19 |
| 313.31 | 2.35 | 2.35 |
| 337.38 | 3.02 | 3.02 |
| 345.35 | 3.29 | 3.29 |
| 317.25 | 2.38 | 2.38 |
| 360.71 | 2.66 | 2.66 |
| 345.30 | 2.81 | 2.81 |
| 345.30 | 2.81 | 2.81 |
| 388.76 | 3.09 | 3.09 |
| 345.30 | 2.73 | 2.73 |
| 388.76 | 3.01 | 3.01 |
| 387.38 | 3.72 | 3.72 |
| 331.27 | 2.42 | 2.42 |
| 364.18 | 3.45 | 3.45 |
| 364.18 | 3.45 | 3.45 |
| 374.74 | 2.70 | 2.70 |
| 327.31 | 2.59 | 2.59 |
| 381.28 | 3.30 | 3.30 |
| 347.73 | 2.93 | 2.93 |
| 358.28 | 2.19 | 2.19 |
| 347.73 | 2.93 | 2.93 |
| 374.74 | 2.70 | 2.70 |
| 392.18 | 3.04 | 3.04 |
| 374.74 | 2.70 | 2.70 |
| 388.22 | 3.21 | 3.21 |
| 330.73 | 2.19 | 2.19 |
| 309.32 | 2.45 | 2.45 |
| 313.28 | 2.28 | 2.28 |
| 329.74 | 2.79 | 2.79 |
| 340.29 | 2.05 | 2.05 |
| 351.40 | 3.44 | 3.44 |
| 365.43 | 3.87 | 3.87 |
| 374.19 | 2.90 | 2.90 |
| 331.27 | 2.42 | 2.42 |
| 331.27 | 2.42 | 2.42 |
| 331.27 | 2.42 | 2.42 |
| 331.27 | 2.42 | 2.42 |
| 331.27 | 2.42 | 2.42 |
| 329.74 | 2.79 | 2.79 |
| 340.29 | 2.05 | 2.05 |